Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Apr 27, 2023; 15(4): 687-697
Published online Apr 27, 2023. doi: 10.4240/wjgs.v15.i4.687
Published online Apr 27, 2023. doi: 10.4240/wjgs.v15.i4.687
Table 6 Comparison of postoperative complications and 1-year survival rate in groups, n (%)
Complications | TACE group (n = 119) | TACE + TARE group (n = 99) | χ2 | P value |
Fever | 6 (5.04) | 6 (6.06) | 0.976 | 0.743 |
Hydrothorax | 16 (13.45) | 15 (5.05) | 0.869 | 0.720 |
Cholecystitis | 4 (3.36) | 6 (6.06) | 0.533 | 0.343 |
Hepatic encephalopathy | 15 (12.61) | 9 (9.09) | 0.543 | 0.409 |
Total complication rate | 41 (34.45) | 36 (36.37) | 0.880 | 0.769 |
1-yr survival rate | 25 (21.00) | 33 (33.33) | 0.058 | 0.040 |
- Citation: Feng R, Cheng DX, Song T, Chen L, Lu KP. Efficacy and safety analysis of transarterial chemoembolization and transarterial radioembolization in advanced hepatocellular carcinoma descending hepatectomy. World J Gastrointest Surg 2023; 15(4): 687-697
- URL: https://www.wjgnet.com/1948-9366/full/v15/i4/687.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i4.687